Evidence map›Paper›PMID 36609332›Full record

ArticleBMJ open2023

Factors influencing participation in randomised clinical trials among patients with early Barrett's neoplasia: a multicentre interview study.

Mohammad Farhad Peerally, Clare Jackson, Pradeep Bhandari, Krish Ragunath, Hugh Barr, Clive Stokes, Rehan Haidry, Laurence B Lovat, Howard Smart, John De Caestecker

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in BMJ open, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.5field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 9 institutions in 2 countries.

Mohammad Farhad PeerallySAPPHIRE, Department of Health Sciences, University of Leicester, Leicester, UK mfp6@le.ac.uk.ORCID 0000-0003-3004-375X
Clare JacksonFaculty of Medicine and Health Sciences, University of Nottingham, Nottingham, UK.
Pradeep BhandariQueen Alexandra Hospital, Portsmouth, UK.
Krish RagunathDepartment of Gastroenterology & Hepatology, Royal Perth Hospital, Perth, Western Australia, Australia.ORCID 0000-0001-6571-5435
Hugh BarrDepartment of Surgery, Gloucestershire Royal Hospital, Gloucester, UK.
Clive StokesChestnut House, Gloucester Royal Hospital, Gloucester, UK.
Rehan HaidryDepartment of Gastroenterology and Hepatology, University College Hospital, London, UK.
Laurence B LovatDivision of Surgery and Interventional Science, University College London, London, UK.
Howard SmartDepartment of Gastroenterology, Royal Liverpool Hospital, Liverpool, UK.
John De CaesteckerDigestive Diseases Centre, University Hospitals of Leicester NHS Trust, Leicester, UK.
Gloucestershire Royal Hospital · GBCurtin University · AUQueen Alexandra Hospital · GBUniversity College Hospital · GBUniversity College London · GBUniversity Hospitals of Leicester NHS Trust · GBUniversity of Leicester · GBUniversity of Liverpool · GBUniversity of Nottingham · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesStrong recruitment and retention into randomised controlled trials involving invasive therapies is a matter of priority to ensure better achievement of trial aims. The BRIDE (Barrett's Randomised Intervention for Dysplasia by Endoscopy) Study investigated the feasibility of undertaking a multicentre randomised controlled trial comparing argon plasma coagulation and radiofrequency ablation, following endoscopic resection, for the management of early Barrett's neoplasia. This paper aims to identify factors influencing patients' participation in the BRIDE Study and determine their views regarding acceptability of a potential future trial comparing surgery with endotherapy.

designA semistructured telephone interview study was performed, including both patients who accepted and declined to participate in the BRIDE trial. Interview data were analysed using the constant comparison approach to identify recurring themes.

settingInterview participants were recruited from across six UK tertiary centres where the BRIDE trial was conducted.

participantsWe interviewed 18 participants, including 11 participants in the BRIDE trial and 7 who declined.

resultsFour themes were identified centred around interviewees' decision to accept or decline participation in the BRIDE trial and a potential future trial comparing endotherapy with surgery: (1) influence of the recruitment process and participant-recruiter relationship; (2) participants' views of the design and aim of the study; (3) conditional altruism as a determining factor and (4) participants' perceptions of surgical risks versus less invasive treatments.

conclusionWe identified four main influences to optimising recruitment and retention to a randomised controlled trial comparing endotherapies in patients with early Barrett's-related neoplasia. These findings highlight the importance of qualitative research to inform the design of larger randomised controlled trials.

Indexed as

Barrett EsophagusEsophageal NeoplasmsPrecancerous ConditionsHumansNeoplasm Recurrence, LocalQualitative ResearchRandomized Controlled Trials as TopicAdult gastroenterologyEndoscopyOesophageal disease

Identifiers

PMID36609332
PMCPMC9827249
OpenAlexW4313649893

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.